Morris, MD, section head of prostate cancer and attending physician at Memorial Sloan Kettering Cancer Center (MSKCC), is well known for his work in the development of targeted radioimaging and theranostic agents, including his leading role in the Phase 3 clinical trials, OSPREY and CONDOR
Your healthcare provider can help adjust your treatment plan or recommend other diabetes medication if needed
Consumers Taking GLP-1s for Weight Loss, Current or Discontinued, Drive Lasting Changes in Retail, Per New Acosta Group Study News provided by Acosta Group Apr 14, 2025, 12:05 ET 76% of those who discontinued GLP-1s are eating the same amount or less and many report retaining healthy habits JACKSONVILLE, Fla., April 14, 2025 /PRNewswire/ -- In advance of the National Association of Chain Drug Stores (NACDS) Annual Meeting, Acosta Group is sharing the results of its recent proprietary GLP-1 Shopper Community study, focusing on consumers using the medications specifically to support weight loss
Can GLP-1s reduce cravings for alcohol or other substances
